期刊
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
卷 86, 期 2, 页码 244-249出版社
WILEY
DOI: 10.1111/bcp.14180
关键词
benzodiazepines; insomnia; melatonin; orexin receptor antagonists; suvorexant; Z drugs
Insomnia and, more generally, lack of sleep are on the rise. Traditionally treated by classical hypnotics, such as benzodiazepines and Z drugs, which both act on the GABA(A) receptor, and other modalities, including nondrug therapies, such as cognitive behavioural therapy, there is a range of new hypnotics which are being developed or have recently received market approval. Suvorexant and the like target the orexin/hypocretin system: they should have less side effects in terms of drug-drug interactions with e.g. alcohol, less memory impairment and dependence potential compared to classical hypnotics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据